Ng Teng Fong General Hospital is a 700-bed hospital located in Jurong East, Singapore. Named after Singaporean late entrepreneur, Ng Teng Fong, the hospital is part of an integrated development together with the adjoining Jurong Community Hospital.

There are 700 beds in Ng Teng Fong General Hospital.

During the past decade, Ng Teng Fong General Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ng Teng Fong General Hospital" #1 sponsor was "National University Hospital, Singapore" with 8 trials, followed by "Concept Medical Inc." with 2 trials sponsored, "Azienda Ospedaliero-Universitaria Careggi" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "JurongHealth" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ng Teng Fong General Hospital" #1 collaborator was "National University of Singapore" with 2 trials as a collaborator, "Ng Teng Fong General Hospital" with 2 trials as a collaborator, "Tan Tock Seng Hospital" with 2 trials as a collaborator, "Alexandra Hospital" with 1 trials as a collaborator and "Baxter Healthcare Corporation" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Ng Teng Fong General Hospital" are "Atrial Fibrillation" (3 trials), "Atherosclerosis" (2 trials), "Breast Cancer" (2 trials), "Peripheral Artery Disease" (2 trials) and "Arterial Disease" (1 trials). Many other conditions were trialed in "Ng Teng Fong General Hospital" in a lesser frequency.

Most popular intervention types in "Ng Teng Fong General Hospital" are "Device" (6 trials), "Drug" (6 trials), "Other" (4 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ablation therapy (AT)" (1 trials), "Active Surveillance (AS)" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ng Teng Fong General Hospital" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ng Teng Fong General Hospital". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ng Teng Fong General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ng Teng Fong General Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".

Ng Teng Fong General Hospital has several departments that took part in Clinical trials: "Ng Teng Fong General Hospital - Infectious Disease Service" - 3 trials